RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Mezzion Pharma Co Stock

Mezzion Pharma Co P/S 2024

Mezzion Pharma Co P/S

23.37

Ticker

140410.KQ

ISIN

KR7140410002

As of Dec 20, 2024, Mezzion Pharma Co's P/S ratio stood at 23.37, a 42.15% change from the 16.44 P/S ratio recorded in the previous year.

The Mezzion Pharma Co P/S history

Mezzion Pharma Co Aktienanalyse

What does Mezzion Pharma Co do?

Mezzion Pharma Co Ltd is a biopharmaceutical company based in South Korea, focused on the development and commercialization of therapeutics for the treatment of heart diseases. The company was founded in 2009 and has been listed on the Korea Stock Exchange since 2014. Mezzion Pharma Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Mezzion Pharma Co's P/S Ratio

Mezzion Pharma Co's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Mezzion Pharma Co's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Mezzion Pharma Co's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Mezzion Pharma Co’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Mezzion Pharma Co stock

What is the price-to-earnings ratio of Mezzion Pharma Co?

The price-earnings ratio of Mezzion Pharma Co is currently 23.37.

How has the price-earnings ratio of Mezzion Pharma Co changed compared to last year?

The price-to-earnings ratio of Mezzion Pharma Co has increased by 42.15% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Mezzion Pharma Co high compared to other companies?

Yes, the price-to-earnings ratio of Mezzion Pharma Co is high compared to other companies.

How does an increase in the price-earnings ratio of Mezzion Pharma Co affect the company?

An increase in the price-earnings ratio of Mezzion Pharma Co would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Mezzion Pharma Co affect the company?

A decrease in the price-earnings ratio of Mezzion Pharma Co would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Mezzion Pharma Co?

Some factors that influence the price-earnings ratio of Mezzion Pharma Co are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Mezzion Pharma Co pay?

Over the past 12 months, Mezzion Pharma Co paid a dividend of 8.33 KRW . This corresponds to a dividend yield of about 0.03 %. For the coming 12 months, Mezzion Pharma Co is expected to pay a dividend of 0 KRW.

What is the dividend yield of Mezzion Pharma Co?

The current dividend yield of Mezzion Pharma Co is 0.03 %.

When does Mezzion Pharma Co pay dividends?

Mezzion Pharma Co pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Mezzion Pharma Co?

Mezzion Pharma Co paid dividends every year for the past 0 years.

What is the dividend of Mezzion Pharma Co?

For the upcoming 12 months, dividends amounting to 0 KRW are expected. This corresponds to a dividend yield of 0 %.

In which sector is Mezzion Pharma Co located?

Mezzion Pharma Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Mezzion Pharma Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Mezzion Pharma Co from 4/1/2013 amounting to 25 KRW, you needed to have the stock in your portfolio before the ex-date on 12/27/2012.

When did Mezzion Pharma Co pay the last dividend?

The last dividend was paid out on 4/1/2013.

What was the dividend of Mezzion Pharma Co in the year 2023?

In the year 2023, Mezzion Pharma Co distributed 0 KRW as dividends.

In which currency does Mezzion Pharma Co pay out the dividend?

The dividends of Mezzion Pharma Co are distributed in KRW.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Mezzion Pharma Co

Our stock analysis for Mezzion Pharma Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mezzion Pharma Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.